These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Transition-state stabilization as a measure of the efficiency of antibody catalysis. Stewart JD; Benkovic SJ Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931 [TBL] [Abstract][Full Text] [Related]
44. A structural basis for the activity of retro-Diels-Alder catalytic antibodies: evidence for a catalytic aromatic residue. Hugot M; Bensel N; Vogel M; Reymond MT; Stadler B; Reymond JL; Baumann U Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9674-8. PubMed ID: 12093912 [TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of single chain anti-cocaine catalytic antibodies. McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858 [TBL] [Abstract][Full Text] [Related]
46. Crystal structures of Paenibacillus polymyxa beta-glucosidase B complexes reveal the molecular basis of substrate specificity and give new insights into the catalytic machinery of family I glycosidases. Isorna P; Polaina J; Latorre-García L; Cañada FJ; González B; Sanz-Aparicio J J Mol Biol; 2007 Aug; 371(5):1204-18. PubMed ID: 17585934 [TBL] [Abstract][Full Text] [Related]
47. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity. Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492 [TBL] [Abstract][Full Text] [Related]
48. Structural origins of efficient proton abstraction from carbon by a catalytic antibody. Debler EW; Ito S; Seebeck FP; Heine A; Hilvert D; Wilson IA Proc Natl Acad Sci U S A; 2005 Apr; 102(14):4984-9. PubMed ID: 15788533 [TBL] [Abstract][Full Text] [Related]
49. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution. Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943 [TBL] [Abstract][Full Text] [Related]
50. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues. Hrmova M; Fincher GB Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065 [TBL] [Abstract][Full Text] [Related]
51. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment. Kuhar MJ; Carroll FI; Bharat N; Landry DW Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184 [TBL] [Abstract][Full Text] [Related]
52. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies. Johnson G; Moore SW J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205 [TBL] [Abstract][Full Text] [Related]
53. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process. Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540 [TBL] [Abstract][Full Text] [Related]